FLT3 and kidney disorder: Syk may represent an interesting target for various renal diseases.36 However, R788 (fostamatinib) and its active metabolite R406 may also inhibit fms-like tyrosine kinase 3 (Flt3) at the tested concentrations, so their inhibitory activity may not be solely due to inhibition of Syk (Suppl.